Results 251 to 260 of about 2,615,972 (289)
Some of the next articles are maybe not open access.
Homocystinuria: Therapeutic approach
Clinica Chimica Acta, 2016Homocystinuria is a disorder of sulfur metabolism pathway caused by deficiency of cystathionine β-synthase (CBS). It is characterized by increased accumulation of homocysteine (Hcy) in the cells and plasma. Increased homocysteine results in various vascular and neurological complications.
Tarun, Kumar +2 more
openaire +2 more sources
Gastroenterology Clinics of North America, 1995
Clinicians have witnessed an evolution from sulfasalazine and hydrocortisone to alternative aminosalicylates and steroids. Revolutionary changes beyond these, however, and other "nonspecific" anti-immunoinflammatory compounds require clarification of the primary events either activating inflammatory cascades or preventing the down-regulation of ...
S B, Hanauer, M I, Schulman
openaire +2 more sources
Clinicians have witnessed an evolution from sulfasalazine and hydrocortisone to alternative aminosalicylates and steroids. Revolutionary changes beyond these, however, and other "nonspecific" anti-immunoinflammatory compounds require clarification of the primary events either activating inflammatory cascades or preventing the down-regulation of ...
S B, Hanauer, M I, Schulman
openaire +2 more sources
combining therapeutic approaches
Journal of Psychosocial Nursing and Mental Health Services, 1977It would seem on the surface that psychotherapeutic approaches as different as psychoanalysis and behavioral therapy have little in common. In fact, they seem to be similar in terms of expectation of help, nonconfirming experiences, informational learning, changes in self-concept, reinforcement/influence, paradox, and problem solving.
openaire +2 more sources
Therapeutic Approaches in Myositis
Current Rheumatology Reports, 2011The inflammatory myopathies are a heterogeneous group of diseases including dermatomyositis, polymyositis, and inclusion body myositis. Few clinical trials have been conducted in myositis, making it difficult to provide clear recommendations on the treatment of these rare disorders. Although corticosteroids have not been tested in randomized controlled
Rohit, Aggarwal, Chester V, Oddis
openaire +2 more sources
Therapeutic approaches to cellulite
Seminars in Cutaneous Medicine and Surgery, 2015Cellulite is a condition that affects the vast majority of women. Although it is of no danger to one's overall health, cellulite can be psychosocially debilitating. Consequently, much research has been devoted to understanding cellulite and its etiopathogenesis.
Jeremy B, Green +4 more
openaire +2 more sources
Therapeutic Approaches in CLIPPERS
Current Treatment Options in Neurology, 2017CLIPPERS for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids, is a steroid-sensitive and steroid-dependent brainstem inflammatory disease of unknown origin. Since its first description in 2010, about 60 cases have been reported throughout the world.
Guillaume, Taieb +2 more
openaire +2 more sources
Therapeutic Approaches to Osteoarthritis
Hospital Practice, 1997Management is multifaceted: Palliation of pain should be accompanied by physical and occupational therapy and use of adaptive devices to improve performance. New techniques aim to interrupt disease progression and to induce biologic repair.
J A, Block, T J, Schnitzer
openaire +2 more sources
Lymphangioleiomyomatosis: New Therapeutic Approaches
Archivos de Bronconeumología (English Edition), 2011Lymphangioleiomyomatosis (LAM) is a rare disease that affects young women of child-bearing age. It is characterized by the presence of cystic changes in the pulmonary parenchyma, repeated pneumothorax, chylothorax and renal angiomyolipomas, and in the majority of cases it is accompanied by a progressive loss in lung function.1 In the last two decades ...
Alvaro, Casanova, Julio, Ancochea
openaire +2 more sources
Therapeutic approaches in myelofibrosis
Expert Opinion on Pharmacotherapy, 2011Myeloproliferative neoplasm (MPN)-associated myelofibrosis is the most disabling of the classical Philadelphia-negative MPNs. The discovery that a gain-of-function mutation of JAK2 (JAK2V617F) is present in more than 60% of patients with MPN-associated myelofibrosis has provided a new target for innovative treatment strategies.This review discusses the
G. Barosi +2 more
openaire +3 more sources